Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non‐small‐cell lung cancer-Reference-Cited by-同舟云学术

Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non‐small‐cell lung cancer

Published:2022-12-15 Issue:5 Volume:14 Page:442-449
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Kurokawa Kana¹^ORCID,Mitsuishi Yoichiro¹,Shimada Naoko¹,Ito Naoaki²,Ogiwara Misa¹,Miura Keita¹^ORCID,Asao Tetsuhiko¹,Ko Ryo¹^ORCID,Shukuya Takehito¹^ORCID,Shibayama Rina¹,Goto Hiromasa²,Takahashi Kazuhisa¹

Affiliation:

1. Department of Respiratory Medicine Juntendo University Faculty of Medicine and Graduate School of Medicine Tokyo Japan

2. Department of Metabolism and Endocrinology Juntendo University Faculty of Medicine and Graduate School of Medicine Tokyo Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14761

Reference23 articles.

2. Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis

4. Association Between Immune-related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Non–small-cell Lung Cancer

5. Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics and outcomes of patients with primary liver cancer and immune checkpoint inhibitor-associated adrenal insufficiency: A retrospective cohort study;International Immunopharmacology;2024-01

2. Clinical characteristics and treatment efficacy of immune checkpoint inhibitors (ICIs) in patients with ICIs-induced Adrenal insufficiency;Translational Oncology;2023-12

3. Pembrolizumab-Induced Adrenal Insufficiency Presenting Eight Months After Cessation of Treatment;Cureus;2023-06-27

4. Inflammatory and Infectious Disorders in Endocrine Pathology;Endocrine Pathology;2023-05-20